What Researchers Did
The authors wrote a narrative review of how oxygen therapy, including hyperbaric oxygen therapy (HBOT) and topical oxygen therapy, relates to wound healing and to molecular markers in diabetic foot ulcers.
What They Found
This narrative review of oxygen therapy in diabetic foot ulcers describes how oxygen is thought to act in wound healing and which molecular biomarkers have been identified, without reporting trial figures. The abstract says the data suggest oxygen therapy promotes wound healing through angiogenesis, the creation of new blood vessels. It says certain biomarkers have been linked to angiogenesis and inflammation, which it calls two crucial parts of wound healing. It also describes clinical outcomes such as collagen formation, angiogenesis, respiratory burst and cell proliferation, and it states that oxygen therapy benefits some patients, not all.
What This Means for Canadian Patients
For people with diabetic foot ulcers, the abstract says oxygen therapy is currently guided by clinical examination and imaging. It says predictive biomarkers can be used to identify patients most likely to benefit, but it does not report that this has changed care. The abstract gives no treatment pressures, session numbers or patient results.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review, not a trial, so it reports no patient numbers or measured treatment effects, and the abstract does not describe how the evidence was selected.